By Nascent Biotech Posted May 10, 2023 In Corporate News NBIO Link Report for May 10, 20232023-05-102023-05-10http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttps://www.nascentbiotech.com/wp-content/uploads/2022/01/nascent-articles.jpg200px200px 0 Wall Street PR Apple News StreetInsider.com QuoteMedia WallStreetPR Facebook LinkedIn Recent PostsNascent Biotech to Begin Phase II Clinical Trials for Brain CancerBenzinga: Why NBIO is a Biotech Bargain Basement Deal with Underappreciated PotentialJournal of Clinical Oncology: Phase 1 study of pritumumab in brain cancer.Nascent Biotech Regains Worldwide Rights for Pritumumab
